Selection for arsenite resistance causes reversible changes in minicircle composition and kinetoplast organization in Leishmania mexicana.
Certain minor minicircle sequence classes in the kinetoplast DNA (kDNA) networks of arsenite- or tunicamycin-resistant Leishmania mexicana amazonensis variants whose nuclear DNA is amplified appear to be preferentially selected to replicate (S. T. Lee, C. Tarn, and K. P. Chang, Mol. Biochem. Parasitol. 58:187-204, 1993). These sequences replace the predominant wild-type minicircle sequences to become dominant species in the kDNA network. The switch from wild-type-specific to variant-specific minicircles takes place rapidly within the same network, the period of minicircle dominance changes being defined as the transition period. To investigate the structural organization of the kDNA networks during this transition period, we analyzed kDNA from whole arsenite-resistant Leishmania parasites by dot hybridization with sequence-specific DNA probes and by electron-microscopic examination of isolated kDNA networks in vitro. Both analyses concluded that during the switch of dominance the predominant wild-type minicircle class was rapidly lost and that selective replication of variant-specific minicircles subsequently filled the network step by step. There was a time during the transition when few wild-type- or variant-specific minicircles were present, leaving the network almost empty and exposing a species of thick, long, fibrous DNA which seemed to form a skeleton for the network. Both minicircles and maxicircles were found to attach to these long DNA fibrils. The nature of the long DNA fibrils is not clear, but they may be important in providing a framework for the network structure and a support for the replication of minicircles and maxicircles.
Lee
S T
ST
Laboratory of Molecular Parasitology, Academia Sinica, Taipe, Taiwan, Republic of China.
Liu
H Y
HY
Lee
S P
SP
Tarn
C
C
D000818:Animals; D018053:Arsenites / Q000494:pharmacology*; D002417:Cattle; D004250:DNA Topoisomerases, Type II / Q000494:pharmacology; D018105:DNA, Kinetoplast / Q000187:drug effects / Q000648:ultrastructure*; D004351:Drug Resistance / Q000235:genetics; D014644:Genetic Variation; D007894:Leishmania mexicana / Q000187:drug effects* / Q000235:genetics / Q000648:ultrastructure*; D008854:Microscopy, Electron
D018053:Arsenites; D018105:DNA, Kinetoplast; D004250:DNA Topoisomerases, Type II; C015001:arsenite